Arcadia Biosciences, Inc. financial data

Symbol
RKDA on Nasdaq
Industry
Crude Petroleum & Natural Gas
Location
202 Cousteau Place, Suite 105, Davis, United States
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Mar 25, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 421 % -23%
Quick Ratio 43.5 % -26.4%
Debt-to-equity 61.2 % +1.9%
Return On Equity -73.3 % +18.1%
Return On Assets -45.3 % +18.7%
Operating Margin -72.3 % +47.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.37M shares +0.31%
Common Stock, Shares, Outstanding 1.36M shares +6.19%
Entity Public Float 4.18M USD +0.36%
Common Stock, Value, Issued 65K USD 0%
Weighted Average Number of Shares Outstanding, Basic 1.36M shares +10.2%
Weighted Average Number of Shares Outstanding, Diluted 1.36M shares +10.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 5.05M USD +13.3%
Research and Development Expense 53K USD -17.2%
Costs and Expenses 8.69M USD -17.6%
Operating Income (Loss) -3.65M USD +40.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -1.18M USD -85%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -7.04M USD +49.7%
Earnings Per Share, Basic -5.17 USD/shares +54.2%
Earnings Per Share, Diluted -5.17 USD/shares +54.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.24M USD -34.9%
Inventory, Net 904K USD +8.01%
Assets, Current 9.24M USD -38.3%
Property, Plant and Equipment, Net 41K USD -41.4%
Operating Lease, Right-of-Use Asset 137K USD -82.7%
Intangible Assets, Net (Excluding Goodwill) 39K USD 0%
Other Assets, Noncurrent 92K USD -43.9%
Assets 13.5M USD -31.4%
Employee-related Liabilities, Current 962K USD -14%
Liabilities, Current 2.56M USD -28.6%
Operating Lease, Liability, Noncurrent 0 USD -100%
Other Liabilities, Noncurrent 2M USD 0%
Liabilities 7.29M USD +4.17%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD -100%
Retained Earnings (Accumulated Deficit) -279M USD -2.59%
Stockholders' Equity Attributable to Parent 6.22M USD -51.5%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 6.22M USD -51%
Liabilities and Equity 13.5M USD -31.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.21M USD +7.39%
Net Cash Provided by (Used in) Financing Activities 5M USD -9.17%
Net Cash Provided by (Used in) Investing Activities 4M USD +1170%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 1.36M shares +6.19%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.2M USD -236%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 28.4M USD -6.97%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Operating Lease, Liability 155K USD -84.6%
Depreciation 58K USD -47.7%
Payments to Acquire Property, Plant, and Equipment 13K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -7.14M USD +48.6%
Lessee, Operating Lease, Liability, to be Paid 155K USD -85.1%
Property, Plant and Equipment, Gross 1.91M USD -5.22%
Operating Lease, Liability, Current 155K USD -81.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 156K USD -82.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 155K USD -82.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure +16.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 35K USD -72.9%
Deferred Tax Assets, Operating Loss Carryforwards 25.3M USD +9.4%
Unrecognized Tax Benefits 16K USD 0%
Amortization of Intangible Assets 0 USD -100%
Deferred Tax Assets, Net of Valuation Allowance 28.4M USD -7.37%